Mahima Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 5.99 M
as on 17-11-2024
- Company Age 28 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.15 Cr
as on 17-11-2024
- Satisfied Charges ₹ 2.50 Cr
as on 17-11-2024
- Revenue -16.13%
(FY 2023)
- Profit -52.32%
(FY 2023)
- Ebitda -64.95%
(FY 2023)
- Net Worth 5.94%
(FY 2023)
- Total Assets 0.09%
(FY 2023)
About Mahima Lifesciences
The Corporate was formerly known as Mahima Exports Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.99 M.
The company currently has active open charges totaling ₹28.15 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pramod Mittal and Rajeev Goel serve as directors at the Company.
- CIN/LLPIN
U51311DL1996PTC083943
- Company No.
083943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mahima Lifesciences Private Limited offer?
Mahima Lifesciences Private Limited offers a wide range of products and services, including Building & Real Estate Developers, Construction Service, Inspection & Quality Check Services, Quality Inspection Service, ISO & Quality Management Consultants, Certification Services.
Who are the key members and board of directors at Mahima Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Mittal  | Director | 12-Jun-2006 | Current |
| Rajeev Goel | Director | 01-Jun-2011 | Current |
Financial Performance of Mahima Lifesciences.
Mahima Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.13% decrease. The company also saw a substantial fall in profitability, with a 52.32% decrease in profit. The company's net worth moved up by a moderate rise of 5.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahima Lifesciences?
In 2023, Mahima Lifesciences had a promoter holding of 29.58% and a public holding of 70.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Oct 2023 | ₹10.10 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Oct 2007 | ₹18.05 Cr | Open |
Union Bank Of India Creation Date: 27 Mar 2006 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Mahima Lifesciences?
Mahima Lifesciences has a workforce of 33 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahima Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahima Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
